10x Genomics, Inc. reported the results of its annual meeting of stockholders held on June 4, 2026. Stockholders approved the election of three Class I directors, ratified the appointment of Ernst & Young LLP as the independent auditor, and approved the executive compensation of named executive officers on an advisory basis.
